WallStSmart
CRDF

Cardiff Oncology Inc

NASDAQ: CRDF · HEALTHCARE · BIOTECHNOLOGY

$1.73
+6.79% today

Updated 2026-04-30

Market cap
$117.60M
P/E ratio
P/S ratio
198.31x
EPS (TTM)
$-0.69
Dividend yield
52W range
$1 – $5
Volume
0.7M

Cardiff Oncology Inc (CRDF) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200520092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-4.40M$-1.23M$-2.09M$-1.93M$-4.93M$-7.32M$-12.73M$-22.12M$-31.04M$-23.28M$-13.20M$-13.27M$-16.31M$-23.04M$-33.82M$-30.89M$-37.69M$-37.92M
Capital expenditures$0.00$10000.00$27747.00$1528.00$270080.00$649284.00$363290.00$2.24M$823000.00$100000.00$5100.00$68000.00$211880.00$205000.00$892000.00$582000.00$80000.00$44000.00
Depreciation
Stock-based comp$3.59M$325930.00$250978.00$532140.00$1.98M$2.07M$3.95M$7.50M$4.01M$2.17M$885000.00$1.76M$3.23M$4.26M$4.51M$4.76M$5.69M
Free cash flow$-4.40M$-1.24M$-2.12M$-1.93M$-5.20M$-7.97M$-13.09M$-24.36M$-31.86M$-23.38M$-13.21M$-13.34M$-16.53M$-23.25M$-34.71M$-31.47M$-37.77M$-37.97M
Investing cash flow
Financing cash flow
Dividends paid$60741.00$23.02M$24.24M$24.24M$24.24M$24.24M$24.24M$24.24M$24000.00$414000.00
Share repurchases
Debt repayment
Net change in cash$15.02M$1.46M$40.20M$-53.58M$-5.69M$3.23M$-1.26M$120.79M$-119.04M$4.40M